# PULM catalysts: Pulmatrix, Inc. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/pulm/catalysts

> Pulmatrix, Inc. (PULM) has no upcoming catalysts in this calendar. The latest recorded is the Pulmatrix, Inc. earnings report, August 13, 2026.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only, exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | Pulmatrix, Inc. |
| Ticker | PULM (Nasdaq) |
| SEC CIK | 1574235 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/pulm |

## Cash runway

Cash $2.2M as of 2026-06-30; quarterly burn $1.1M; about 5.9 months of runway at that rate (XBRL company facts, accession 0001493152-26-037594).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Sep 2023 | [PUR3100 NDA/BLA acceptance](https://sec-api.dev/pdufa/pur3100) | PULM |  | completed | "We received Food and Drug Administration ("FDA") acceptance of our Investigational New Drug Application ("IND") and a "study may proceed" letter in September 2023, positioning PUR3100 as Phase 2-ready for potential financing or partnership discussions." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1574235/000149315226023368/form10-q.htm)) |
| March 21, 2025 | [Pulmatrix, Inc. earnings report](https://sec-api.dev/companies/pulm/catalysts) | PULM |  | completed | "Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1574235/000149315225011082/ex99-1.htm)) |
| August 6, 2025 | [Pulmatrix, Inc. earnings report](https://sec-api.dev/companies/pulm/catalysts) | PULM |  | completed | "Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1574235/000164117225022354/ex99-1.htm)) |
| October 16, 2025 | [Pulmatrix, Inc. earnings report](https://sec-api.dev/companies/pulm/catalysts) | PULM |  | completed | "Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1574235/000149315225018252/ex99-1.htm)) |
| February 26, 2026 | [Pulmatrix, Inc. earnings report](https://sec-api.dev/companies/pulm/catalysts) | PULM |  | completed | "Announces Year-End and Fourth Quarter 2025 Financial Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1574235/000149315226008129/ex99-1.htm)) |
| May 15, 2026 | [Pulmatrix, Inc. earnings report](https://sec-api.dev/companies/pulm/catalysts) | PULM |  | completed | "Announces First Quarter 2026 Financial Results" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1574235/000149315226023367/ex99-1.htm)) |
| August 13, 2026 | [Pulmatrix, Inc. earnings report](https://sec-api.dev/companies/pulm/catalysts) | PULM |  | completed | "Announces Second Quarter 2026 Financial Results and Progress on Merger" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1574235/000149315226037592/ex99-1.htm)) |

## Drugs

- [PUR3100](https://sec-api.dev/pdufa/pur3100): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/pulm/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "PULM catalysts: Pulmatrix, Inc. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/pulm/catalysts

```bibtex
@misc{secapidev_companies_pulm_catalysts_20261116,
  title        = {PULM catalysts: Pulmatrix, Inc. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/pulm/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_pulm_catalysts_20261116","title":"PULM catalysts: Pulmatrix, Inc. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/pulm/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
